DUAKLIR

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug DUAKLIR contains a combination of these active pharmaceutical ingredients (APIs):

1 Aclidinium UNII UQW7UF9N91 - ACLIDINIUM BROMIDE

Aclidinium is a competitive, selective muscarinic receptor antagonist (also known as an anticholinergic), with a longer residence time at the M3 receptors than the M2 receptors. M3 receptors mediate contraction of airway smooth muscle. Inhaled aclidinium acts locally in the lungs to antagonise M3 receptors of airway smooth muscle and induce bronchodilation. Read about Aclidinium

2 Eformoterol UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. Read about Eformoterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DUAKLIR GENUAIR Inhalation powder	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AL05	Formoterol and aclidinium bromide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02439530
Country: EE	Ravimiamet	Identifier(s): 1669710, 1669721, 1727849
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114964001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 077994, 454210
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 283575
Country: HK	Department of Health Drug Office	Identifier(s): 64503
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7812
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075095, 1075096, 1080832
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 122734
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100332957
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69355001
Country: SG	Health Sciences Authority	Identifier(s): 15231P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786550131, 8699786550148, 8699786550155
Country: US	FDA, National Drug Code	Identifier(s): 72124-001